Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Albers

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Brain Research|July 15, 2015
Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combinationFaisal K Alkholifi, David S Albers
Neurochemistry International|February 19, 2002
Mitochondrial dysfunction in progressive supranuclear palsyDavid S Albers, M Flint Beal
Brain Research|September 17, 2002
Stress-induced mitochondrial depolarization and oxidative damage in PSP cybridsJason W Chirichigno, Giovanni Manfredi, M Flint Beal, et al.
Experimental Neurology|December 4, 2002
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's diseaseStefan Lorenzl, David S Albers, Sabine Narr, et al.
American Journal of Pharmaceutical Education|November 20, 2013
Educational and career goals of pharmacy students upon graduationMattia M Migliore, Ryan C Costantino, Nicholas A Campagna, et al.
Journal of Neurodevelopmental Disorders|March 27, 2026
Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2 deletion syndrome (ZYN2-CL-031)Helen Heussler, Jonathan Cohen, Caroline B Buchanan, et al.
Journal of the Neurological Sciences|February 5, 2004
Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsyStefan Lorenzl, David S Albers, Jason W Chirichigno, et al.
Advances in Neurology|September 27, 2003
Dopamine transmission in DYT1 dystoniaSarah J Augood, Z Hollingsworth, David S Albers, et al.
Investigative Ophthalmology & Visual Science|July 20, 2018
Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye SyndromeAgne Žiniauskaite, Symantas Ragauskas, Jenni J Hakkarainen, et al.
Translational Vision Science & Technology|December 28, 2019
Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)Yan Guo, Zara Mehrabian, Mary A Johnson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Brain Research|July 15, 2015
Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combinationFaisal K Alkholifi, David S Albers
Neurochemistry International|February 19, 2002
Mitochondrial dysfunction in progressive supranuclear palsyDavid S Albers, M Flint Beal
Brain Research|September 17, 2002
Stress-induced mitochondrial depolarization and oxidative damage in PSP cybridsJason W Chirichigno, Giovanni Manfredi, M Flint Beal, et al.
Experimental Neurology|December 4, 2002
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's diseaseStefan Lorenzl, David S Albers, Sabine Narr, et al.
American Journal of Pharmaceutical Education|November 20, 2013
Educational and career goals of pharmacy students upon graduationMattia M Migliore, Ryan C Costantino, Nicholas A Campagna, et al.
Journal of Neurodevelopmental Disorders|March 27, 2026
Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2 deletion syndrome (ZYN2-CL-031)Helen Heussler, Jonathan Cohen, Caroline B Buchanan, et al.
Journal of the Neurological Sciences|February 5, 2004
Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsyStefan Lorenzl, David S Albers, Jason W Chirichigno, et al.
Advances in Neurology|September 27, 2003
Dopamine transmission in DYT1 dystoniaSarah J Augood, Z Hollingsworth, David S Albers, et al.
Investigative Ophthalmology & Visual Science|July 20, 2018
Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye SyndromeAgne Žiniauskaite, Symantas Ragauskas, Jenni J Hakkarainen, et al.
Translational Vision Science & Technology|December 28, 2019
Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)Yan Guo, Zara Mehrabian, Mary A Johnson, et al.
Pageof 2